---
title: "Camelimonas Species Linked to Human Discovertebral Infection in France, 2025"
id: "cdc-emerging-infectious-diseases-journal-1-human-discovertebral-infection-caused-by-camelimonas-species-bacteria-france"
canonical_url: "https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-1-human-discovertebral-infection-caused-by-camelimonas-species-bacteria-france"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "CDC Emerging Infectious Diseases Journal"
source_url: "https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article"
published_at: "2026-11-10T05:00:00.000Z"
evidence_level: "Agency Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Camelimonas Species Linked to Human Discovertebral Infection in France, 2025
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-1-human-discovertebral-infection-caused-by-camelimonas-species-bacteria-france
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** CDC Emerging Infectious Diseases Journal
- **Source URL:** [Original Journal Publication](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article)
- **Published At:** 2026-11-10T05:00:00.000Z
- **Evidence Rating:** Agency Feed
## Executive GIST (TL;DR)
- A single clinical case: a man in his forties with advanced liver disease presented with progressive low back pain and gait impairment; imaging indicated discovertebral infection with a psoas abscess. - Initial blood cultures were negative; diagnosis required two vertebral biopsies because the first biopsy yielded no pathogen. - Aerobic culture from the second biopsy grew a small gram-negative bacillus after prolonged incubation; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry did not identify the isolate. - Whole-genome sequencing and 16S rRNA analysis identified the isolate as a **Camelimonas** species (strain FR25DVI), with ANI and dDDH values below species thresholds, suggesting a novel species closely related to a previously reported human strain. - Antimicrobial susceptibility testing showed low MICs to trimethoprim/sulfamethoxazole (TMP/SMX), doxycycline, and amoxicillin; therapy was started with TMP/SMX plus doxycycline but TMP/SMX was discontinued after 8 days for renal deterioration and replaced by amoxicillin. - The patient completed a 6-week course of amoxicillin plus doxycycline, had symptomatic improvement, and MRI lesions stabilized; six-month follow-up showed no progression but persistent residual lumbar pain. - Investigators reported possible zoonotic exposure given the patient’s occasional work on a cattle farm and prior reports of **Camelimonas** in cattle; plausible routes include direct contact or contaminated raw milk. - The source did not report standardized treatment guidelines, controlled comparative treatment data, or definitive transmission proof; authors emphasized scarcity of human cases and recommended surveillance and further study of pathogenicity and reservoirs.
## Clinical Analysis & Structured Key Points
[Skip directly to page options](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#share-nav) [Skip directly to A-Z link](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#az-large) ![](https://wwwnc.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/us_flag_small.png) An official website of the United States government Here's how you know ![](https://wwwnc.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/icon-dot-gov.svg) **Official websites use .gov** A .gov website belongs to an official government organization in the United States. ![](https://wwwnc.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/icon-https.svg) **Secure .gov websites use HTTPS** A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. [CDC Home](https://wwwnc.cdc.gov/) [ ![Centers for Disease Control and Prevention](https://wwwnc.cdc.gov/TemplatePackage/5.0/img/logo/cdc-logo-tag-right.svg) ](https://www.cdc.gov/) Emerging Infectious Diseases ![](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) [A-Z Index](https://www.cdc.gov/az/) × Submit [A-Z Index](https://www.cdc.gov/az/) × Submit [A-Z Index](https://www.cdc.gov/az/) Search Dropdown × Submit Emerging Infectious Diseases * [About the Journal](https://wwwnc.cdc.gov/eid/about) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **About the Journal** * [General Information](https://wwwnc.cdc.gov/eid/about/general) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **General Information** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **About the Journal****General Information** * [Background and Goals](https://wwwnc.cdc.gov/eid/about/background) * [Editors](https://wwwnc.cdc.gov/eid/about/editors) * [Editorial Board](https://wwwnc.cdc.gov/eid/about/editorial-board) * [Staff](https://wwwnc.cdc.gov/eid/about/staff) * [ Home](https://wwwnc.cdc.gov/) * [Contact](https://wwwnc.cdc.gov/eid/contact) * [EID Journal Report 2025](https://wwwnc.cdc.gov/eid/pdfs/JournalReport_2025.pdf) * [ Home](https://wwwnc.cdc.gov/) * [Articles](https://wwwnc.cdc.gov/eid/) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Articles** * [November 2026](https://wwwnc.cdc.gov/eid/current) * [Wastewater Surveillance](https://wwwnc.cdc.gov/eid/articles/issue/32/13/table-of-contents) * [Early Release](https://wwwnc.cdc.gov/eid/early-release) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Early Release** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Articles****Early Release** * [Human Discovertebral Infection Caused by Camelimonas Species Bacteria, France, 2025](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Human Discovertebral Infection Caused by Camelimonas Species Bacteria, France, 2025** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Early Release****Human Discovertebral Infection Caused by Camelimonas Species Bacteria, France, 2025** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Articles****Early Release****Human Discovertebral Infection Caused by Camelimonas Species Bacteria, France, 2025** * [Figure 1](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f1) * [Figure 2](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f2) * [Appendix](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-app1.pdf) * [ Home](https://wwwnc.cdc.gov/) * [ Home](https://wwwnc.cdc.gov/) * [Past Issues](https://wwwnc.cdc.gov/eid/past-issues/volume-32) * [Medscape CME](https://wwwnc.cdc.gov/eid/articles/cme) * [ICEID](https://wwwnc.cdc.gov/eid/page/iceid) * [ Home](https://wwwnc.cdc.gov/) * [Search](https://wwwnc.cdc.gov/eid/Search) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Search** * [Advanced Article Search](https://wwwnc.cdc.gov/eid/AdvancedSearch) * [Articles by Country Search](https://wwwnc.cdc.gov/eid/ArticleMap) * [Spotlight Topics](https://wwwnc.cdc.gov/eid/spotlight) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Spotlight Topics** * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Search****Spotlight Topics** * [Antimicrobial Resistance Spotlight](https://wwwnc.cdc.gov/eid/spotlight/antimicrobial-resistance) * [Coronavirus Spotlight](https://wwwnc.cdc.gov/eid/spotlight/coronavirus) * [Ebola Spotlight](https://wwwnc.cdc.gov/eid/spotlight/ebola) * [Etymologia](https://wwwnc.cdc.gov/eid/articles/etymologia) * [Foodborne Diseases and Outbreaks Spotlight](https://wwwnc.cdc.gov/eid/spotlight/foodborne-diseases) * [Fungal Diseases](https://wwwnc.cdc.gov/eid/spotlight/fungal) * [Hantavirus Spotlight](https://wwwnc.cdc.gov/eid/spotlight/hantavirus) * [HIV/AIDS Spotlight](https://wwwnc.cdc.gov/eid/spotlight/hiv) * [Influenza Spotlight](https://wwwnc.cdc.gov/eid/spotlight/influenza) * [Lyme Disease Spotlight](https://wwwnc.cdc.gov/eid/spotlight/lyme-disease) * [Malaria Spotlight](https://wwwnc.cdc.gov/eid/spotlight/malaria) * [MERS Spotlight](https://wwwnc.cdc.gov/eid/spotlight/mers) * [Mpox Spotlight](https://wwwnc.cdc.gov/eid/spotlight/mpox) * [Pneumonia Spotlight](https://wwwnc.cdc.gov/eid/spotlight/pneumonia) * [Rabies Spotlight](https://wwwnc.cdc.gov/eid/spotlight/rabies) * [Ticks Spotlight](https://wwwnc.cdc.gov/eid/spotlight/ticks) * [Tuberculosis/Mycobacteria](https://wwwnc.cdc.gov/eid/spotlight/tuberculosis) * [Zika Spotlight](https://wwwnc.cdc.gov/eid/spotlight/zika) * [ Home](https://wwwnc.cdc.gov/) * [Article Type Search](https://wwwnc.cdc.gov/eid/ArticleTypeSearch) * [EID on PubMed Central](https://www.ncbi.nlm.nih.gov/pmc/journals/782/) * [ Home](https://wwwnc.cdc.gov/) * [Subscribe](https://wwwnc.cdc.gov/eid/subscriptions) * [Author Resource Center](https://wwwnc.cdc.gov/eid/page/author-resource-center) * [Peer Reviewers](https://wwwnc.cdc.gov/eid/reviewers) * [Podcasts](https://wwwnc.cdc.gov/eid/podcasts) * [ BACK ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) **Podcasts** * [Search](https://wwwnc.cdc.gov/eid/podcasts/search) * [ Home](https://wwwnc.cdc.gov/) * [Social Media](https://wwwnc.cdc.gov/eid/page/social-media) * [ Press & Media Information](https://wwwnc.cdc.gov/eid/press) * [ Home](https://wwwnc.cdc.gov/) 1. [EID Journal](https://wwwnc.cdc.gov/eid/) 2. [Volume 32](https://wwwnc.cdc.gov/eid/early-release) 3. [Early Release](https://wwwnc.cdc.gov/eid/early-release#issue-1348) 4. [Main Article](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) * [Facebook](https://www.facebook.com/sharer/sharer.php?u=%2Feid%2Farticle%2F32%2F12%2F26-0924_article "Share to Facebook") * [Twitter](http://twitter.com/share?url=%2Feid%2Farticle%2F32%2F12%2F26-0924_article&text= "Share to Twitter") * [LinkedIn](https://www.linkedin.com/shareArticle?url=%2Feid%2Farticle%2F32%2F12%2F26-0924_article&title= "Share to LinkedIn") * [Syndicate](https://tools.cdc.gov/medialibrary/index.aspx#/sharecontent//eid/article/32/12/26-0924_article "Embed this Page") [ Emerging Infectious Disease journal ISSN: 1080-6059 ](https://wwwnc.cdc.gov/eid/) _Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released._ #### Volume 32, Number 12—December 2026 ##### _Research Letter_ ### Human Discovertebral Infection Caused by _Camelimonas_ Species Bacteria, France, 2025 On This Page [Research Letter](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) * * * [Suggested Citation](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) Figures [Figure 1](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f1) * * * [Figure 2](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f2) Downloads [Appendix ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-app1.pdf) * * * [RIS [TXT - 2 KB] ](https://wwwnc.cdc.gov/eid/article/32/12/26-0924.ris) Article Metrics [Metric Details](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article) Louis Chombart, Alice Blosse, Arnaud Desclaux, Quentin Jehanne, Frédéric Antoine Dauchy, Didier Neau, Rudie Beinat, Stanislas Dubreil, Audrey Toirot, Armelle Ménard[1](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#fn1), and Xavier Brousse[1](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#fn1)[![Comments to Author](https://wwwnc.cdc.gov/eid/content/images/icon/email.gif)](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#comment) Author affiliation: Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France (L. Chombart, A. Blosse, A. Desclaux, Q. Jehanne, F.A. Dauchy, D. Neau, R. Beinat, S. Dubreil, A. Toirot, A. Ménard, X. Brousse); Université de Bordeaux, BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Bordeaux (Q. Jehanne, A. Ménard) [Suggested citation for this article](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#suggestedcitation) ### Abstract We describe a case of human _Camelimonas_ species infection, highlighting this bacterium as a potential emerging zoonotic pathogen with bone tropism. Diagnosis required repeated biopsies and genome sequencing. The isolate was susceptible to trimethoprim/sulfamethoxazole and doxycycline; clinical improvement followed prolonged therapy. Our findings support this bacterium’s pathogenic role in humans. Discovertebral infection (DVI) is the most common hematogenous osteomyelitis in persons >50 years of age and typically involves intervertebral disks and adjacent vertebral bodies. Diagnosis relies on clinical, radiologic, microbiological, and histopathological findings ([_1_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r1 "1")). Primary manifestations are neurologic compression and residual posttreatment pain. Gram-positive cocci, primarily _Staphylococcus aureus_ bacteria, coagulase-negative staphylococci, and streptococci, are the most common pathogens ([_2_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r2 "2")). We describe DVI caused by _Camelimonas_ species bacterium in France. In May 2025, a man in his forties was referred to Bordeaux University Hospital with gait impairment and 4 months of low back pain that had worsened progressively over the preceding 2 months. His history included Child-Pugh C alcoholic cirrhosis (MELD 23), for which he was awaiting liver transplantation. A transjugular intrahepatic portosystemic shunt had been placed 2 years earlier. He had controlled diabetes mellitus and took only analgesics and rifaximin for hepatic encephalopathy prevention. He lived in the countryside, occasionally helped on his father’s cattle farm, and had not traveled abroad recently. Figure 1 ![Imaging from study of human discovertebral infection caused by Camelimonas species bacteria, France, 2025. T1-weighted axial magnetic resonance imaging after gadolinium injection shows discovertebral infection associated with secondary abscess formation in the right psoas muscle \(yellow arrow\) and epidural inflammation causing canal narrowing \(white arrow\).](https://wwwnc.cdc.gov/eid/images/26-0924-F1-tn.jpg) [Figure 1](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f1 "Figure 1"). Imaging from study of human discovertebral infection caused by _Camelimonas_ species bacteria, France, 2025. T1-weighted axial magnetic resonance imaging after gadolinium injection shows discovertebral infection associated with secondary abscess... Previous computed tomography showed multilevel disc degeneration; L4–L5 discopathy was suggestive of DVI, characterized by erosion of the superior L5 vertebral end-plate and right perivertebral tissue infiltration. Diagnosis was confirmed by magnetic resonance imaging (MRI), revealing anterior epidural inflammatory infiltration, canal narrowing, right neural foramen extension, and psoas muscle abscess ([Figure 1](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f1)). Results of multiple blood cultures were negative, but tests for panfungal blood markers were repeatedly positive (β-D-glucan >10 pg/mL, galactomannan antigen >1.2). A computed tomography–guided vertebral biopsy performed 10 days after MRI yielded negative bacteriology, mycology, and histology. Thus, another biopsy was performed 1 month later. Mycological cultures and targeted PCRs for _Aspergillus_ species, _A. fumigatus_ , and Mucorales fungi were performed, all with negative results. However, aerobic culture of biopsy (37°C, 5% carbon dioxide) grew a small gram-negative bacillus after 62 hours ([Appendix](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-app1.pdf) Figure, panel A). Colonies were gray, translucent, smooth, 0.2–0.5 mm in diameter, nonhemolytic ([Appendix](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-app1.pdf) Figure, panel B), oxidase- and catalase-positive, and strictly aerobic, demonstrating fastidious growth on Drigalski and bromocresol purple agar media. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification failed ([Appendix](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-app1.pdf) Figure, panel C). Figure 2 ![Phylogenetic and genomic relatedness of Camelimonas isolate FR25DVI from study of human discovertebral infection caused by Camelimonas species bacteria, France, 2025. A\) Evolutionary relationships of Camelimonas taxa based on the 16S ribosomal RNA. The tree was inferred using the maximum-likelihood method and the Jukes-Cantor model in MEGA12 \(https://www.megasoftware.net\); branch support was assessed through 1,000 bootstrap replicates. The final dataset consisted of 8 aligned nucleotide sequences and 1,346 positions after complete deletion of gaps. Blast 16S ribosomal RNA sequence showed highest similarity with human Camelimonas strain ID_303_24 \(98.87% similarity; 1,395/1,411 bp\), followed by C. lactis M2040T \(98.16% similarity; 1,385/1,411 bp\), C. fluminis XZ2T \(98.09% similarity; 1,384/1,411 bp\), and C. abortus UK34/07–5T \(96.11%; 1,358/1,413 bp\). A Chelatococcus species sequence was used as an outgroup. Sequence taxa are labeled by species, strain name, GenBank accession number, isolation source, and country. Scale bar indicates number of substitutions per site. B, C\) Average nucleotide identity \(ANI; B\), and digital DNA–DNA hybridization \(dDDH\) values \(C\) between isolate FR25 DVI and available Camelimonas genomes. Reference genomes include type strains for C. lactis \(M2040T\), C. fluminis \(XZ2T\), and C. abortus \(UK34/07–5T\), alongside the human Camelimonas sp. strain ID_303_24. The highest similarity was observed against strain ID_303_24 \(ANI 82.3%, panel B\) and C. abortus UK34/07–5T \(dDDH 23.3%, panel C\), well below the standard >95% ANI and >70% dDDH thresholds for species demarcation, suggesting that isolate FR25 DVI represents a novel Camelimonas species. T, type strain.](https://wwwnc.cdc.gov/eid/images/26-0924-F2-tn.jpg) [Figure 2](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f2 "Figure 2"). Phylogenetic and genomic relatedness of _Camelimonas_ isolate FR25DVI from study of human discovertebral infection caused by _Camelimonas_ species bacteria, France, 2025. A) Evolutionary relationships of ... Phylogenetic analysis based on the 16S ribosomal RNA gene of strain FR25DVI ([Figure 2](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f2), panel A) suggests a novel _Camelimonas_ species near human _Camelimonas_ strain ID_303_24 and more distant from _C. lactis_ M2040T and _C._ _fluminis_ XZ2T. The genome size was 4,292,006 bp (63% guanine-cytosine content). Comparisons with available _Camelimonas_ genomes showed average nucleotide identity and digital DNA–DNA hybridization values below species thresholds. The highest similarity was with human _Camelimonas_ ID_303_24 (82.3% identity) and _C. abortus_ UK34/07-5T (23.3% hybridization) sequences ([Figure 2](https://wwwnc.cdc.gov/eid/article/32/12/26-0924-f2), panels B and C). Given the scarcity of human _Camelimonas_ cases, the absence of sepsis or neurologic compression, and the positive biopsy, another vertebral biopsy was performed 3 weeks later. Culture and sequencing confirmed the growth of _Camelimonas_ species bacteria. Antibiotic susceptibility testing showed low MICs: 0.016 mg/L for trimethoprim/sulfamethoxazole (TMP/SMX), 0.25 mg/L for doxycycline, and 2 mg/L for amoxicillin. Therapy with TMP/SMX (800/160 mg 3×/day) and doxycycline (100 mg 2×/day) was started; TMP/SMX was stopped after 8 days because of renal deterioration and replaced by amoxicillin (2 g 4×/day) for 6 weeks ([_3_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r3 "3")). The patient also wore a rigid brace. The 6-week amoxicillin/doxycycline course was well tolerated, resulting in reduced pain and stabilized MRI lesions. Clinical evaluation confirmed symptomatic improvement, and antibiotics were discontinued. Six months after treatment, the patient showed progress and had no evidence of disease progression, although residual lumbar pain persisted. _Camelimonas_ is a gram-negative, aerobic, non–spore-forming, short rod-shaped bacterium of the Beijerinckiaceae family (Gammaproteobacteria). Isolated from camel milk in the United Arab Emirates in 2010 ([_4_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r4 "4")), it was later identified in the environment ([_5_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r5 "5")), bovine placenta ([_6_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r6 "6")), and human blood ([_7_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r7 "7")). We describe a human _Camelimonas_ discovertebral bacterial infection in a young man with advanced liver disease. Sequencing identified _Camelimonas_ species bacteria in 2 biopsies. Culture-guided dual antibiotic therapy resolved the infection after 6 weeks. Repeated microbiological isolation, combined with the patient’s cattle farm exposure, strongly support its clinical significance. Cattle are a recognized reservoir for the bacterium ([_4_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r4 "4"),[_6_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r6 "6")), but the patient reported no illness in the herd. Plausible transmission routes include direct zoonotic contact with infected animals or consumption of contaminated raw milk. Furthermore, the patient’s underlying liver disease likely caused relative immunosuppression, enabling the infection. _Camelimonas_ sp. bacterium has been associated with abortions in cattle ([_6_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r6 "6")) and has been isolated from blood in an immunocompromised human ([_7_](https://wwwnc.cdc.gov/eid/article/32/12/26-0924_article#r7 "7")), indicating its ability to cross mucosal barriers and disseminate systemically. Its tropism for collagen-rich tissues, such as vertebrae and intervertebral disks, likely provides a suitable substrate for bacterial adhesion and colonization. Because no standardized antibiotic guidelines exist for _Camelimonas_ infections, treatment relied on oral bioavailability and bone-penetrating agents. However, renal impairment necessitated a change from TMP/SMX to amoxicillin, resulting in a prolonged course of amoxicillin and doxycycline. This case demonstrates a pathogenic role for _Camelimonas_ species bacteria in humans. The pathogen appears to have a bone tropism, warranting consideration in the differential diagnosis of subacute discovertebral infection, particularly in patients who have dairy farm exposure. Dr. Chombart is a pulmonology resident at the Bordeaux University Hospital in France. He is part
## Related Clinical Research

- [Increased risk of acute gastroenteritis after COVID-19 hospitalisation: a retrospective England an](https://medichelpline.com/clinical-feed/medrxiv-3-risk-of-acute-gastroenteritis-following-covid-19-exposure-a-retrospective.md)
- [Undiagnosed type 2 diabetes presenting as DKA with hypertriglyceridemia-induced acute pancreatitis](https://medichelpline.com/clinical-feed/cmaj-1-undiagnosed-type-2-diabetes-presenting-as-diabetic-ketoacidosis-with.md)
- [Safety and Uptake of COVID-19, Influenza, and Pertussis Vaccination in Pregnancy: Australian Cohor](https://medichelpline.com/clinical-feed/pubmed-42667899.md) (DOI: 10.1016/j.vaccine.2026.129081)
- [Mycobacterium africanum Lineage 6 Identified in White-Nosed Coatis in Costa Rica](https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-0-detection-of-mycobacterium-africanum-lineage-6-in-white-nosed-coatis-costa-rica.md)
- [Amoxicillin Associated with Increased Mortality in Animal Influenza A Model](https://medichelpline.com/clinical-feed/biorxiv-12-amoxicillin-worsens-mortality-from-viral-respiratory-tract-infection.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.